In addition, the reduced activities of E-cadherin, αE-catenin, and afadin have been reported: For instance, inactivating mutations of E-cadherin are frequently detected in infiltrating lobular breast carcinomas and in diffuse gastric cancer (62). The gene discussed is CDH1; the disease is invasive lobular breast carcinoma.